Attached files

file filename
EX-32.1 - EXHIBIT 32.1 - Card Activation Technologies Incex32_1.htm
EX-31.1 - EXHIBIT 31.1 - Card Activation Technologies Incex31_1.htm


United states
Securities and Exchange Commission
Washington, D.C. 20549
____________________
FORM 10-Q
____________________
 
(Mark One)
x  Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the quarterly period ended December 31, 2009

o  Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act

For the transition period from __________ to __________
__________________

Commission File Number: 0-52556
____________________
Card Activation Technologies, Inc.
(Exact name of registrant as specified in its charter)

Delaware
20-5769015
(State or other jurisdiction of incorporation or organization)
(I.R.S. Employer Identification No.)
   
53 West Jackson Blvd., Suite 1618
Chicago, Illinois
60604-3749
(Address of principal executive offices)
(Zip Code)

(312) 972-1662
(Registrant's telephone number, including area code)
 
Indicate by check mark whether the registrant (1) has filed all reports required by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days:  Yes   x     No   ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files.  Yes   ¨     No   ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non–accelerated filer, or a smaller reporting company. See definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b–2 of the Exchange Act.
 
Large accelerated filer  ¨
Accelerated filer  ¨
Non–Accelerated filer  ¨ (Do not check if a smaller reporting company)
Smaller reporting company  x

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b–2 of the Exchange Act).  Yes  ¨    No  x

As of February 10, 2010, the issuer had 174,782,045 shares of common stock, $0.001 par value per share, outstanding.
 


 
 

 

TABLE OF CONTENTS
 


PART I – FINANCIAL INFORMATION

ITEM 1.  FINANCIAL STATEMENTS

CARD ACTIVATION TECHNOLOGIES, INC.

UNAUDITED CONDENSED BALANCE SHEETS


   
December 31, 2009
   
September 30, 2009
 
             
CURRENT ASSETS
           
Cash
  $ 39,416     $ 6,909  
Investments
    25,000       25,000  
Settlement receivable
          237,500  
Advances to affiliate
    1,262,088       1,072,050  
Total current assets
    1,326,504       1,341,459  
TOTAL ASSETS
  $ 1,326,504     $ 1,341,459  
                 
LIABILITIES AND STOCKHOLDERS' EQUITY:
               
                 
CURRENT LIABILITIES:
               
Accounts payable
  $ 43,848     $ 51,522  
Accrued expenses
    150,085       242,857  
Total current liabilities
    193,933       294,379  
TOTAL LIABILITIES
  $ 193,933     $ 294,379  
                 
STOCKHOLDERS' EQUITY:
               
Preferred stock, $.001 par value, 1,000,000 shares authorized; none issued and outstanding as of December 31, 2009 and September 30, 2009, respectively
           
Common stock, $.0001 par value, 300,000,000 shares authorized; 174,782,045 and 174,782,045 shares issued and outstanding as of December 31, 2009 and September 30, 2009, respectively
    17,478       17,478  
Additional paid in capital
    1,509,953       1,509,953  
Accumulated deficit
    (394,860 )     (480,351 )
Total stockholders' equity
    1,132,571       1,047,080  
                 
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY
  $ 1,326,504     $ 1,341,459  

The accompanying notes are an integral part of these condensed financial statements.


CARD ACTIVATION TECHNOLOGIES, INC.

UNAUDITED CONDENSED STATEMENTS OF OPERATIONS

   
Three Months Ended
December 31,
 
   
2009
   
2008
 
REVENUE
           
Litigation revenue
  $ 250,000     $ 375,000  
Total
    250,000       375,000  
                 
COSTS AND EXPENSES
               
Cost of revenue
    87,500       131,250  
General and administrative
    98,004       351,097  
Sales and marketing expenses
          4,940  
Total operating expenses
    185,504       487,287  
OPERATING INCOME (LOSS)
    64,496       (112,287 )
                 
OTHER (INCOME) AND EXPENSES
               
Interest income
    (21,348 )     (8,995 )
Interest expense
    353        
Total other (income) expense
    (20,995 )     (8,995 )
                 
INCOME (LOSS) BEFORE INCOME TAXES
    85,491       (103,291 )
                 
INCOME TAX (BENEFIT) PROVISION
           
                 
NET INCOME (LOSS)
  $ 85,491     $ (103,291 )
                 
Weighted Average Common Shares Outstanding:
               
Basic and diluted:
    174,782,045       172,255,167  
                 
Net Income (Loss) Per Share:
               
Basic and diluted:
  $ (0.00 )   $ (0.00 )
 
The accompanying notes are an integral part of these condensed financial statements.


CARD ACTIVATION TECHNOLOGIES, INC.

UNAUDITED CONDENSED STATEMENTS OF CASH FLOWS
 
   
Three Months Ended
December 31,
 
   
2009
   
2008
 
CASH FLOWS FROM OPERATING ACTIVITIES:
           
Net income (loss)
  $ 85,491     $ (103,291 )
Adjustments to reconcile net income to net cash (used in) operating activities:
               
Common stock issued for services
          17,088  
Changes in assets and liabilities:
               
Settlement receivable
    237,500        
Accounts payables
    (7,674 )     92,980  
Accrued expenses
    (92,772 )     (21,884 )
Net cash provided by (used in) operating activities
    222,545       (15,107 )
                 
CASH FLOWS FROM FINANCING ACTIVITIES:
               
Advances to affiliates
    (194,270 )     (178,995 )
Proceeds from the sale of stock
          102,500  
Advances from affiliates
    4,232       284,557  
Net cash provided by (used in) financing activities
    (190,038 )     208,062  
                 
INCREASE IN CASH
    32,507       192,955  
CASH, BEGINNING OF YEAR
    6,909        
CASH, END OF YEAR
  $ 39,416     $ 192,955  
                 
Supplemental Cash Flow Information:
               
Issuance of stock for affiliate acquisition
  $     $ 294,000  
 
The accompanying notes are an integral part of these condensed financial statements.


CARD ACTIVATION TECHNOLOGIES, INC.
NOTES TO CONDENSED FINANCIAL STATEMENTS
(Unaudited)


Note 1.   Background

Card Activation Technologies, Inc. (“we,” “us,” “our” or the “Company”) was incorporated in the state of Delaware on August 29, 2006. The Company was incorporated in order to own and commercially develop our patented point-of-sale technology for the activation and processing of transactions related to debit styled cards, which include gift cards, phone cards and other stored value cards.  We also vigorously defend our patent and actively litigate infringements related to the unauthorized use of our technology.  The patent was transferred to us by MedCom USA, Incorporated (“MedCom”) upon our formation in exchange for 146,770,504 shares of our common stock.  The patent covers the technology and process for taking a card with a magnetic strip or other data capture mechanism and activating the card by downloading a determined monetary value onto the card for use at a later date for different types of transactions.

Note 2.   Basis of Presentation

The accompanying condensed financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America which contemplate continuation of the Company as a going concern.   During the three months ended December 31, 2009, the Company recognized net income of $85,491.  However, the Company incurred an accumulated net loss from period August 29, 2006 (inception) through December 31, 2009 of $394,860.  Further, the Company has inadequate working capital to maintain or develop its operations, and is dependent upon funds from private investors and the support of certain stockholders.

These factors raise substantial doubt about the ability of the Company to continue as a going concern.  The financial statements do not include any adjustments that might result from the outcome of these uncertainties.  In this regard, our management is proposing to raise any necessary additional funds through loans and additional sales of our common stock. There is no assurance that the Company will be successful in raising additional capital.

The accompanying condensed financial statements included herein have been prepared by us, without audit, in accordance with the accounting policies described in our audited financial statements and notes thereto for the fiscal year ended September 30, 2009, as presented in our annual report on Form 10-K, and pursuant to the rules and regulations of the Securities and Exchange Commission, or the SEC.  Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States have been condensed or omitted pursuant to such rules and regulations, although we believe that the disclosures are adequate to make the information presented not misleading.  In the opinion of our management, the accompanying condensed financial statements include all adjustments (consisting only of those of a normal recurring nature), which are necessary for a fair presentation of the results for the interim periods presented.  Interim results are not necessarily indicative of results to be expected for any future interim period or for the entire fiscal year.

These condensed financial statements should be read in conjunction with the notes to the 2009 audited financial statements presented in our annual report on Form 10-K for the year ended September 30, 2009, filed with the SEC.  Our reports are available electronically by visiting the SEC website at http://www.sec.gov.


Recent Accounting Guidance

On September 30, 2009, the Company adopted updates issued by the Financial Accounting Standards Board (FASB) to the authoritative hierarchy of GAAP. These changes establish the FASB Accounting Standards Codification (ASC) as the source of authoritative accounting principles recognized by the FASB to be applied by nongovernmental entities in the preparation of financial statements in conformity with GAAP. Rules and interpretive releases of the Securities and Exchange Commission (“SEC”) under authority of federal securities laws are also sources of authoritative GAAP for SEC registrants. The FASB will no longer issue new standards in the form of Statements, FASB Staff Positions, or Emerging Issues Task Force Abstracts; instead the FASB will issue Accounting Standards Updates. Accounting Standards Updates will not be authoritative in their own right as they will only serve to update the Codification. These changes and the Codification itself do not change GAAP. Other than the manner in which new accounting guidance is referenced, the adoption of these changes had no impact on the Financial Statements.

In June 2009, the FASB issued guidance now codified as ASC Topic 105, “Generally Accepted Accounting Principles” (“ASC 105”), which establishes the FASB Accounting Standards Codification as the source of GAAP to be applied to nongovernmental agencies. ASC 105 explicitly recognizes rules and interpretive releases of the SEC under authority of federal securities laws as authoritative GAAP for SEC registrants. ASC 105 became effective for interim or annual periods ending after September 15, 2009. ASC 105 does not have a material impact on the Company’s financial statements presented hereby.

In May 2009, the FASB issued guidance now codified as ASC Topic 855, “Subsequent Events” (“ASC 855”). The pronouncement modifies the definition of what qualifies as a subsequent event—those events or transactions that occur following the balance sheet date, but before the financial statements are issued, or are available to be issued—and requires companies to disclose the date through which it has evaluated subsequent events and the basis for determining that date. The Company adopted the provisions of ASC 855 on September 30 2009, in accordance with the effective date.

On June 30, 2009, the Company adopted updates issued by the FASB to fair value disclosures of financial instruments.  These changes require a publicly traded company to include disclosures about the fair value of its financial instruments.  Such disclosures include the fair value of all financial instruments, for which it is practicable to estimate that value, whether recognized or not recognized in the statement of financial position; the related carrying amount of these financial instruments; and the method(s) and significant assumptions used to estimate the fair value.  Other than the required disclosures, the adoption of these changes had no impact on the Financial Statements.

Note 3.   Related Party Transactions
 
As of December 31, 2009, the Company was managed by its sole officer and director, Robert Kite.  Michael De La Garza previously served as a director of the Company and as the Company’s President and Chief Executive Officer.  On April 27, 2009, holders of more than a majority of the outstanding shares of the Company’s common stock, acting by written consent, effected the removal of Mr. De La Garza from the Company’s Board of Directors.  Following Mr. De La Garza’s removal as a director by stockholders, Mr. Kite, the Company’s sole director, acted to remove Mr. De La Garza from his position as President and Chief Executive Officer.  Mr. Kite now serves as sole director and Chairman of the Company’s Board of Directors and acts as the Company’s principal executive and principal financial officer.  Mr. Kite also serves as chairman of the board of directors, president and chief executive officer of MedCom, a related party, and owns shares of common stock of both MedCom and the Company.  MedCom is also a significant shareholder of the Company.
 
On June 4, 2009, the Company entered into a settlement agreement with Mr. De La Garza, MedCom, certain shareholders of MedCom, Robin De La Garza, Mr. De La Garza’s spouse, PayMed USA, LLC, and Absolute Medical Software Systems, LLC (the “Settlement Agreement”).  The Settlement Agreement resolved pending Arizona state court litigation against Mr. De La Garza, in which the Company’s largest shareholder, MedCom, sought, among other things, injunctive and declaratory relief that Mr. De La Garza was not authorized to act on behalf of MedCom as an officer or director.  The Settlement Agreement became final and effective on August 11, 2009.

Under the terms of the Settlement Agreement, Mr. De La Garza affirmed in writing that he holds no position with the Company, whether as an officer, a director or otherwise, and he resigned from any such position to the extent he could be said to hold any such position, which resolved any potential disputes relating to his removal from such offices in April 2009, as discussed above.

 
As of December 31, 2009 and 2008, the Company had a receivable from affiliate advances in the amount of $1,262,088 and $695,587, respectively.

Note 4.  Commitments and Contingencies

The Company enters into contingency agreements with law firms that represent the Company in patent litigation.  Under these agreements, the Company typically pays a law firm thirty five percent of the settlement amounts received by the Company and amounts based on future patent litigation successes.
 
The Company was a party to litigation in federal court involving certain related parties, which was recently dismissed.  The Company was a plaintiff, along with MedCom, in a lawsuit against prior management, Michael Malet and Annette Malet, and William P. Williams, Eva S. Williams and certain of their affiliated entities, Wilcom, Inc., a Texas Corporation, WPW Aircraft LLC, an Arizona Limited Liability Corporation and American Nortel Communications, Inc., a Nevada Corporation, which was filed in February 2009 in the United States District Court in the District of Arizona (Case No. 2:09-cv-00298).  The Company alleged nine causes of action including, among other things, securities fraud, racketeering, and other state law causes of actions, which related to alleged acts arising out of certain of the defendants’ prior service as management of the Company and MedCom.  The Company and MedCom were seeking certain compensatory damages, punitive damages, treble damages, injunctive relief and disgorgement of personal profits and compensation realized by the defendants and reasonable attorneys’ fees, costs and expenses associated with the lawsuit.

In August 2009, the parties filed a stipulation for dismissal without prejudice, which was approved by the court pursuant to an order issued on August 25, 2009.  The parties intend to seek to resolve the claims outside the context of a court proceeding to mitigate expenses.  To this end, the parties have entered in tolling agreements preserving claims against statutes of limitations and other applicable time-based defenses.  If the parties can’t reach a resolution, the Company and MedCom may seek to reinstate the litigation.  The Company is uncertain of the legal costs associated with this suit or its ultimate outcome.


ITEM 2.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

With the exception of historical facts, the matters discussed in this quarterly report on Form 10-Q are forward looking statements.  Forward-looking statements may relate to, among other things, future actions, future performance generally, business development activities, future capital expenditures, strategies, the outcome of contingencies such as legal proceedings, future financial results, financing sources and availability and the effects of regulation and competition.  When we use the words "believe," "intend," "expect," "may," "will," "should," "anticipate," "could," "estimate," "plan," "predict," "project," or their negatives, or other similar expressions, the statements which include those words are usually forward-looking statements.  When we describe strategy that involves risks or uncertainties, we are making forward-looking statements.

These forward-looking statements are based on the current plans and expectations of our management and are subject to certain risks and uncertainties that could cause actual results to differ materially from historical results or those anticipated.  These factors include, but are not limited to:  our ability to protect our patented technology, our failure to satisfy our working capital needs from operations and the availability of and costs associated with potential sources of financing.

We warn you that forward-looking statements are only predictions.  Actual events or results may differ as a result of risks that we face.  Forward-looking statements speak only as of the date they were made, and we undertake no obligation to update them.

The following discussion contains management's discussion and analysis of financial condition and results of operations.  Management's discussion and analysis should be read in conjunction with "Item 1.  Financial Statements" of this quarterly report on Form 10-Q and Management's Discussion and Analysis of Financial Condition and Results of Operations presented in our annual report on Form 10-K for the year ended September 30, 2009.

Overview

We own and commercially develop our patented point-of-sale technology for the activation and processing of transactions related to debit styled cards, which include gift cards, phone cards and other stored value cards.  Currently, our business strategy consists exclusively of attempting to enter into license agreements with third parties to license our rights under our patent and in pursuing patent litigation in an effort to protect our intellectual property and obtain recourse against alleged infringement of our patent.

Results of Operations

Three Months Ended December 31, 2009, Compared to Three Months Ended December 31, 2008

Revenues decreased 33.3% to $250,000 for the three months ended December 31, 2009 from $375,000 for the three months ended December 31, 2008.  The decrease in revenues was due to smaller amounts received for two settlements of patent litigation for the three months ended December 31, 2009 compared to the amounts received for the two settlements during the three months ended December 31, 2008.  There are currently four lawsuits pending and over 600 parties have been notified that they are infringing on our patent.
 
Operating expenses consist of cost of revenue, general and administrative expenses and sales and marketing costs.


Cost of revenue consists of contingency fees paid to legal counsel of 35% of settlement revenue.  Cost of revenue decreased 33.3% to $87,500 for the three months ended December 31, 2009 from $131,250 for the three months ended December 31, 2008 as a result of decreased revenue.
 
General and administrative expenses consist of salaries and benefits, legal, professional and consulting fees, corporate costs, facilities cost, insurance, travel and entertainment.  General and administrative costs decreased 72.1% to $98,005 for the three months ended December 31, 2009 from $351,097 for the three months ended December 31, 2008.  This decrease was primarily due to decreased salaries, benefits and travel and entertainment costs for executives, which was offset by expert witness and other costs related to litigation.
 
Sales and marketing costs decreased 100% to zero for the three months ended December 31, 2009 from $4,940 for the three months ended December 31, 2008 as a result of no marketing efforts.
 
Liquidity and Capital Resources

Our primary sources of liquidity are the sale of our common stock and cash generated from operations.  We had no sales of our common stock and two settlements during the three months ended December 31, 2009.  We expect our future operations will be funded from settlements and revenues from licensing our technology.  However, we may need additional working capital.  Efforts to seek additional finding could be made through equity, debt or other external financing.  Additional funding may not be available on favorable terms, or at all.  If we are unable to obtain additional funding when needed we may not be able to execute our business plans and our business may suffer.

From time to time the Company advances funds to MedCom.  As of December 31, 2009 we were owed $1,262,088 including interest from related parties.

At December 31, 2009, we had cash of $39,416 compared to $6,909 at September 30, 2009.  The net change in cash for the periods presented was comprised of the following:

    December 31, 2009     September 30, 2009  
Cash flow provided by (used in) operating activities
  $ 222,545     $ (15,107 )
Cash flow provided by (used in) financing activities
    (190,038 )     208,062  
 
Cash flow from operating activities was primarily due to net income of $85,491 and cash receipts from settlement receivable $237,500.  These amounts were offset by the pay down of accounts payable and accrued expenses for the three months ended December 31, 2009.  For the three months ended December 31, 2008, we incurred a net loss of $103,291 and incurred approximately $93,000 of accrued expenses which was primarily due to $83,000 of increased receivables related to the settlement receivable.

Cash flow from financing activities was due to net loans to affiliates of approximately $190,000 for the three months ended December 31, 2009 compared to net loans from affiliates of approximately $106,000 and common stock sales of $102,500 for the three months ended December 31, 2008.

Recently Issued Accounting Guidance

On September 30, 2009, the Company adopted updates issued by the Financial Accounting Standards Board (FASB) to the authoritative hierarchy of GAAP. These changes establish the FASB Accounting Standards CodificationTM (ASC) as the source of authoritative accounting principles recognized by the FASB to be applied by nongovernmental entities in the preparation of financial statements in conformity with GAAP. Rules and interpretive releases of the Securities and Exchange Commission (“SEC”) under authority of federal securities laws are also sources of authoritative GAAP for SEC registrants. The FASB will no longer issue new standards in the form of Statements, FASB Staff Positions, or Emerging Issues Task Force Abstracts; instead the FASB will issue Accounting Standards Updates. Accounting Standards Updates will not be authoritative in their own right as they will only serve to update the Codification. These changes and the Codification itself do not change GAAP. Other than the manner in which new accounting guidance is referenced, the adoption of these changes had no impact on the Financial Statements.


In June 2009, the FASB issued guidance now codified as ASC Topic 105, “Generally Accepted Accounting Principles” (“ASC 105”), which establishes the FASB Accounting Standards Codification as the source of GAAP to be applied to nongovernmental agencies. ASC 105 explicitly recognizes rules and interpretive releases of the SEC under authority of federal securities laws as authoritative GAAP for SEC registrants. ASC 105 became effective for interim or annual periods ending after September 15, 2009. ASC 105 does not have a material impact on the Company’s financial statements presented hereby.

In May 2009, the FASB issued guidance now codified as ASC Topic 855, “Subsequent Events” (“ASC 855”). The pronouncement modifies the definition of what qualifies as a subsequent event—those events or transactions that occur following the balance sheet date, but before the financial statements are issued, or are available to be issued—and requires companies to disclose the date through which it has evaluated subsequent events and the basis for determining that date. The Company adopted the provisions of ASC 855 on September 30 2009, in accordance with the effective date.

On June 30, 2009, the Company adopted updates issued by the FASB to fair value disclosures of financial instruments.  These changes require a publicly traded company to include disclosures about the fair value of its financial instruments.  Such disclosures include the fair value of all financial instruments, for which it is practicable to estimate that value, whether recognized or not recognized in the statement of financial position; the related carrying amount of these financial instruments; and the method(s) and significant assumptions used to estimate the fair value.  Other than the required disclosures, the adoption of these changes had no impact on the Financial Statements.

Other Considerations

There are numerous factors that affect the business and the results of its operations.  Sources of these factors include general economic and business conditions, federal and state regulation of business activities, the level of demand for our product, and the ability to develop new products based on new or evolving technology and the market's acceptance of those products.

ITEM 3.  QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Not applicable.

ITEM 4.  CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

Our principal executive officer, who also serves as our principal financial officer, evaluated the effectiveness of the design and operation of our disclosure controls and procedures as such term is defined under Rule 13a-15(e) promulgated under the Securities Exchange Act of 1934, as amended (Exchange Act), as of the end of the period covered by this report.  Based on that evaluation, our principal executive officer has concluded that our disclosure controls and procedures are not effective for ensuring that information required to be disclosed by us in the reports that we file or submit under the Exchange Act, is recorded, processed, summarized and reported within the time periods specified in the SEC's rules and forms.  The Company is in the process of evaluating our disclosure controls and procedures in an effort to develop remedial measures to correct the deficiencies.

Changes in Internal Control Over Financial Reporting

There were no changes in our internal control over financial reporting that occurred during our last fiscal quarter (the quarter ended December 31, 2009) that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.


PART II – OTHER INFORMATION

ITEM 1.  LEGAL PROCEEDINGS

In the ordinary course of business, we are the subject of, or party to, various pending or threatened legal actions, including various counterclaims in connection with our intellectual property enforcement activities.  Card Activation, through its attorneys, has sent letters to over 600 potential infringers of the patent, placing the infringers on notice of the patent and seeking remedies for such infringement. While we believe that any liability arising from these actions will not have a material adverse effect on our financial position, results of operations or cash flows, we can make no assurances that we will not lose all or some of the claims covered by our patent as the result of such actions.
 
Information regarding the Company's legal proceedings outside the ordinary course of business is disclosed under Notes 3 and 4 to the Company's Condensed Financial Statements (unaudited) of Part I of this Quarterly Report on Form 10-Q, which is incorporated herein by reference.
 
ITEM 6.  EXHIBITS
 
Certification of Principal Executive and Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act
   
Certification of Principal Executive and Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

   
Card Activation Technologies, Inc.
 
Dated: February 22, 2010
By:
/s/ Robert Kite
   
Robert Kite
   
Chairman, President and Chief Executive Officer
(Principle Executive Officer and Principal Financial Officer)
 
 
10